Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Eli Lilly and Company
Eli Lilly and Company
Incyte Corporation
Verastem, Inc.
Astellas Pharma Inc
University of Pittsburgh
Eli Lilly and Company
Wake Forest University Health Sciences
AstraZeneca